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Abstract:  
Recent developments in nanotechnology and application of magnetic nanoparticles, in 
particular in magnetic iron oxide nanosystems, offer exciting possibilities for 
nanomedicine. Facile and precise synthesis procedures, high magnetic response, 
tunable morphologies and multiple bio-functionalities of single- and multi-core magnetic 
particles designed for nanomedicine applications are thoroughly appraised. This review 
focuses on the structural and magnetic characterization of the cores, the synthesis of 
single- and multicore iron oxide NPs, especially the design of the latter, as well as their 
protection, stabilization and functionalization by desired coating in order to protect 
against the corrosion of core, to prevent non-specific protein adsorption and particle 
aggregation in biological media, and to provide binding sites for targeting and 
therapeutic agents. 
 
1. Introduction   
Superparamagnetic iron oxide - magnetite and maghemite- nanoparticles are the most 
used constituents of magnetoresponsive nanosystems in the rapidly expanding 
researches and applications in nanomedicine and biology, including magnetic 
resonance imaging, magnetic particle imaging, magnetic drug delivery systems, 
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magnetic fluid hyperthermia and magnetic labeling and separation of cells [1–10].  
Patient safety is an important motivation for a proper choice of magnetic particulate 
systems designed for both diagnosis and therapy (theranostics). To exemplify, iodine or 
gadolinium tracers are hazardous for patients with chronic kidney disease, therefore 
their use as contrast agents is a public health safety concern and requires a safer 
replacement, such as iron oxide nanoparticles (IONPs) [11]. Complex nanosystems of 
coated and multiple functionalized superparamagnetic iron oxide nanoparticles started 
to become the most important tools of nanomedicine [7,9,12,13], as they represent the 
best compromise between good magnetic properties and very reduced toxicity, 
evidenced by extensive in vitro and in vivo tests [14] and by quantitative evaluation of 
biodistribution and local therapeutic effects [12,15]. Other magnetic nanoparticles, like 
Co or FePt [16,17], have higher saturation magnetization and better magnetic response, 
but are toxic, which impedes their use in most of biomedical applications. The US Food 
and Drug Administration (FDA) and the European Medicines Agency (EMA) have 
approved the medical use of only a few iron oxide nanoparticle formulations, most 
probably due to the lack of commonly accepted physicochemical practice of particle 
design and manufacturing, as well as of qualifying criteria. The nanoparticle systems 
involve the magnetic iron oxide core and the sterically and/or electrostatically repulsive 
shell(s) around the core to ensure colloidal stability and salt tolerance in the biological 
environment [18], usually a biocompatible polymer and additionally molecules fulfilling 
the roles of anchors, spacers and various functionalities [19]. The surface engineered 
iron oxide nanoparticles for biomedical applications should be highly water dispersible, 
i.e. the resulted IONP systems should be colloidally stable water based ferrofluids 
[10,19]. 
The synthesis procedures, physicochemical properties, toxicity and biocompatibility, as 
well as vectorization methods of iron oxide nanoparticle systems for biomedical 
applications were thoroughly reviewed along the years in several comprehensive works 
[1,3,5,6,8–10,20]. The basic physical properties of magnetic nanoparticles, the size and 
surface effects on their magnetic behavior (spin canting) and the specific composition, 
structure and functional coatings for biomedical applications, are summarized in 
[4,10,21].  
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The actual composition of magnetic nanoparticles in ferrofluids used in biomedical 
applications involves single core and multicore iron oxide particles [22–25]. The 
multicore particle ferrofluids have the advantage of improved magnetic response of 
particles, while keeping the superparamagnetic behaviour and satisfactory colloidal 
stability in spite of greater hydrodynamic size of dispersed particles, actually iron oxide 
nanoparticle clusters. Therefore the use of multicore products in magnetic targeting and 
hyperthermia treatment is of great importance.  These multicore ferrofluids have to be 
distinguished from single core (‘’true”) ferrofluids [26], both of great interest for 
nanomedicine.  
Polymer based magnetic microspheres encapsulating magnetite nanoparticles were 
proposed already in 1978 by Senyei et al [27] for magnetic drug delivery and targeting. 
The actual high interest for water dispersible surface functionalized multi-core magnetic 
particles is related to the development of more facile and precise synthesis procedures, 
high magnetic response, tunable morphologies and multiple bio-functionalities of 
particles designed for nanomedicine applications. The terms “single core” and 
“multicore” were used more frequently in the last few years; however, they cannot be 
found for example in the excellent book on magnetic nanomaterials [28] or even in 
some recent reviews [3,29], but a review on single versus multi-core iron oxide 
nanoparticles has just appeared [30]. 
The present minireview will focus on recent results on the synthesis and properties of 
surface coated single core and multicore iron oxide nanoparticle systems designed for 
applications in nanomedicine.     
 
2. Structure and magnetic behavior 
  
Magnetic iron oxides - magnetite (Fe3O4) and maghemite ( γ-Fe2O3) - are ferrimagnetic 
materials below their Curie temperatures (850K and 986K respectively [31]). Ferro- and 
ferri-magnets in bulk state present a multidomain magnetic structure, thus without a 
permanent magnetic moment. Reducing the volume of the material to the size range 
specific to magnetic nanoparticles, ferro- and ferri-magnetic particles can be single 
domain with a permanent magnetic moment due to collective spin correlation at the 
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scale of the entire nanoparticle. The properties of usually subdomain size iron oxide 
nanoparticles are no longer similar to bulk materials and motivate the outstanding 
interest for their use in nanomedicine [3,10,13,21]. The size distribution and morphology 
are essential in defining the magnetic behaviour of nanoparticles. The size and shape 
dependent magnetic properties of nanoparticles and nanoparticulate systems, such as 
magnetocrystalline and shape anisotropy, interparticle interactions and magnetic 
relaxation processes, investigated by static and dynamic magnetometry and Mössbauer 
spectroscopy, were thoroughly reviewed in [21,32]. 
Small spherical nanoparticles made of soft magnetic materials with diameter well below 
the domain size show negligible magnetic anisotropy which is why their magnetic 
moment is free to rotate relatively to the particle (Néel effect) and are thus 
superparamagnetic, i.e. paramagnetic below the Curie temperature [21]. The modulus 
of the permanent magnetic moment is given by the product of the volume of the 
monodomain nanoparticle and the domain magnetization, i.e. saturation magnetization     
of the material [33]. The direction of the permanent magnetic moment of the 
nanoparticle is set by the balance between thermal fluctuation and magnetic anisotropy 
that tend to fix it with respect to either crystalline structure (easy magnetization axis / 
axes) or particle morphology (shape anisotropy main axis / axes) [34]. The energy of the 
crystallographic and shape magnetic anisotropy is proportional to the particle volume, 
therefore the smaller the monodomain particle the wider the fluctuation of the magnetic 
moment around the direction of the anisotropy axis. Besides volume proportionality, the 
energy of the shape magnetic anisotropy is increasing with increasing nanoparticle 
morphological anisotropy, i.e. aspect ratio, so that spherical nanoparticles show zero 
shape anisotropy [34]. The volume is also relevant for the strength of the nanoparticle 
interaction with an external magnetic field (dipole-field interaction) as well as with the 
magnetic field generated by another nanoparticle (dipole-dipole interaction) [35]. 
The saturation magnetization of ferro- or ferrimagnetic materials is lower in nanoparticle 
than in bulk state due to either surface or core spin disorder [36]. The surface spin 
disorder breaks the homogeneity of the nanoparticle magnetic structure to a magnetic 
core surrounded by a “dead” magnetic layer of either canted or disordered spins , the 
thickness of this layer being dependent on the chemical reaction between the surfactant 
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and iron oxide nanoparticle [37,38]. The core and surface spin disorder can originate 
from either amorphous or polycrystalline structure as a result of synthesis procedure 
and surface coating [39,40]. The surface spin canting is specific of small nanoparticles, 
while larger size nanoparticles show also volume spin canting. Low TEM size 
polydispersity of magnetic nanoparticles does not guarantee low polydispersity of the 
magnetic dipole moment. Crystal defects, such as twinning and dislocations, can have a 
highly detrimental effect on the strength and low polydispersity of the magnetic 
properties. Crystallite sizes from XRD, volume-averaged TEM and 
magnetogranulometry for iron oxide nanoparticles synthesized by aqueous 
coprecipitation [41,42] and thermal decomposition [43,44] processes show significant 
differences between geometric and magnetic sizes for “twins” and “spheres”, while for 
the “facets”, the “precipitates” and the 8 nm “spheres” TEM and magnetic 
measurements give a similar average size and polydispersity [39].  
The interaction of a magnetic nanoparticle with an external magnetic field is twofold: (1) 
the orientation of the particle’s magnetic moment such that it becomes parallel to the 
applied magnetic field in order to minimize the dipole-field interaction energy [10] and 
(2) the translation of the particle in the direction of the field gradient, i.e 
magnetophoresis [45]. 
The orientation of MNP’s magnetic moment under the action of an external magnetic 
field occurs either by the movement of domain walls in multidomain particles or by the 
rotation in single domain particles. The rotation of the magnetic moment can occur 
either free with respect to the particle (Néel rotation) or together with the particle (Brown 
rotation) [21]. Except for particular situations, the orientation of MNP’s magnetic 
moment in AC magnetic fields shows hysteresis. The phenomenon of AC magnetic 
hysteresis is the basis of magnetic particle hyperthermia [21,46] and susceptometric 
granulometry of single and multicore MNPs [47]. In DC magnetic fields, due to the 
permanent magnetic moment of subdomain MNPs, the magnetization of diluted single 
core particle dispersions follows the Langevin equation which gives the theoretical 
framework for the magnetogranulometry of single core particles [48]. Multicore particles 
have no permanent magnetic moment, provided that the constituent particles are small 
enough such that the magnetic dipole-dipole interaction is negligible. The induced 
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(resultant) magnetic moment of multicore particles is parallel to the external magnetic 
field and follows the Langevin equation. If the constituent particles are large, i.e. the 
anisotropy energy overcomes the thermal energy, the multicore particles show magnetic 
coercivity and remanence due to dipole-dipole interactions. The induced magnetic 
moment of multicore particles at saturation is the sum of the constituent particles’ 
magnetic moments [49]. Many applications of magnetic nanoparticles and 
nanocomposites rely on their ability to be manipulated using magnetic fields. This ability 
depends on the effectiveness of the magnetophoretic force, determined by the particle 
magnetic moment and the field gradient, to fix or to move the particles [45]. The 
magnetophoretic force exerted upon single core superparamagnetic nanoparticles is 
less effective due to their small diameter and magnetic moment implicitly, but in the 
case of multicore composites the resultant field induced magnetic moment is high 
enough in order to allow magnetic targeting already for moderate values of field 
intensity and gradient. Therefore, in order to assess the magnetic targeting / fixing 
applicability of magnetic particles, the particles’ magnetic moment is more relevant than 
mass magnetization [45,50]. The magnetic targeting potential  of multicore particles, in 
particular the magnetic moment and magnetic mobility were determined in recent 
magnetophoresis investigations [45,50-54] (Table 1). 
The synergy between magnetic dipole-dipole and dipole-field interactions may lead to 
magnetically induced clustering in both single and multicore particle liquid dispersions. 
This can cause the complete separation of the magnetic phase from liquid dispersions, 
but most often the formation of spindle shape linear aggregates with dimensions that 
can extend up to several microns diameter and tens to hundreds microns length [49]. 
Magnetically induced linear aggregates of this size have to be avoided by adequate 
physical-chemical design of IONP systems for each nanomedicine application; their 
occurrence can have severe consequences due to the drastic decrease of specific 
surface or the danger of clogging blood capillaries, to mention only a few issues. 
Magnetically induced linear aggregates can occur in both single core [55,56] and 
multicore liquid dispersions [57,58]. The magnetically induced phase condensation in 
single core liquid dispersions can show critical behavior: below a critical temperature 
(Tc) the condensation occurs only at field intensities larger than a critical value 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
(H>Hc(T)) while above the critical temperature the condensation doesn’t occur no 
matter how intense the magnetic field [59]. This critical temperature for a myristic acid 
sterically stabilized single core magnetite water based ferrofluid resulted to be 42.5ºC 
[55], a temperature close to the range of interest for live cell experiments. Phase 
condensation was found to have a negative influence on the effectiveness of magnetic 
nanoparticles’ use as contrast agents in MRI [56] evidenced by` the influence of the 
magnetically induced linear chains in PEG coated single core particle dispersions on the 
proton transverse relaxation rates. It was found that the transverse relaxation rate 
diminishes with increasing particle chaining, i.e. both with increasing field exposure and 
decreasing polymer molecular weight due to specific surface decay. Magnetically 
induced linear aggregates were found to take place in multicore magnetic nanogels [49]. 
The aggregation susceptibility diminishes with increasing temperature. In both single 
core and multicore systems the magnetically induced condensation process may take 
minutes before reaching equilibrium [49,56]. It is worth mentioning that spontaneous 
clustering can also occur in both single core and multicore magnetic particle dispersions 
when the attractive forces (van der Waals, magnetic dipole-dipole) overcome the 
repulsive ones (steric, electrostatic) [56].  
 
3. Single- and multicore iron oxide NPs 
The synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) is a complex 
process because of their colloidal nature [3]. The preparation of colloidal dispersions of 
IONPs, can be accomplished in two ways, (i) dispersion (size reduction to nanometer 
range and dispersing solid phase) of iron or iron oxides in aqueous medium considering 
the classical colloidal routes and (ii) condensation of precursors from either liquid or 
gaseous phase, well-known procedures for ferrofluid preparation  [60], called as top 
down (mechanical attrition) and bottom up (chemical synthesis) methods in fabrication 
of magnetic nanoparticles, in particular of SPIONs for biomedicine [6].   
The huge drawback of dispersion – a non-chemical, simple, top down – way is that it is 
difficult to design and control the process to produce the desired particle size and shape 
[61]. However, the new laser ablation method (named also laser evaporation synthesis) 
for example is really effective to produce enough small particles [62]. This method is 
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suitable for preparation of large amounts of maghemite/magnetite powder from initial 
materials, e.g., coarse hematite, iron powders or even from massive iron blocks. The 
product is a fine powder with average particle size 20–50 nm and a relatively narrow 
size distribution.  
        The bottom-up synthesis procedures  [1,3,6,20],  such as chemical coprecipitation, 
reactions in constrained environments, hydrothermal reactions, high-temperature, sol-
gel reactions, polyol methods, flow injection syntheses, electrochemical, aerosol/vapor 
methods, sonolysis [3],  thermal decomposition, solvothermal reaction [8], hydrolytic and 
non-hydrolytic wet chemistry methods [10], liquid phase, microemulsion and laser 
evaporation syntheses, biomineralization [46], proved to be the most successful ones in 
SPIONs manufacturing.  
The in situ formed NPs spontaneously vary with time mainly in polydisperse systems, 
and ageing processes (Oswald ripening [1]) result in bigger coalesced or irreversible 
adhered NPs as mentioned sometimes in reviews [1] and showed as an example for 
magnetite [63]. The synthesis method most suitable for upscaling is the coprecipitation 
of the stoichiometric mixture of Fe(II) and Fe(III) ions under alkaline (pH>8.5) and 
reductive conditions [64]. The colloidal stability of precipitating systems is determined by 
electrostatic and steric factors [65]. The size of forming crystals is mainly guided by the 
ratio of reaction rates of nucleus formation and crystal growth, while the shape is 
controlled by complex formation on preferred surface sites. The mechanisms of 
nanoparticle growth from solution recently reviewed in [66] evidenced that IONPs 
synthesized by thermal decomposition in non-aqueous solutions follow a classical 
nucleation and growth path [44] and the data are well fitted in the frame of the LaMer 
model. At the same time, the growth of IONPs synthesized by means of chemical 
coprecipitation in aqueous solution follows a non-classical path: primary particles of 
about 1 nm diameter attach to the surface of growing larger particles (Fig.1) [67].  
The alkaline coprecipitation of stoichiometric amounts of ferrous and ferric salts relies 
on the Massart method [41]. In this process, cheap chemicals and mild reaction 
conditions are used and naked magnetite is obtained even in high concentration; it is 
easy to scale up [10]. An excellent analysis on how the superparamagnetic IONP 
formation is influenced by reaction conditions has just been published [68]. The effect of 
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iron salt concentration, reaction temperature, ratio of hydroxide ions to iron ions and 
ratio of Fe(III)/Fe(II) was analyzed. It is worth highlighting that formation of particles 
between 3 and 17 nm with higher saturation magnetization being directly related to the 
bigger particle size are favored at the highest temperature, the highest iron salt 
concentrations, a molar ratio of Fe(III)/Fe(II) below 2:1 and a hyperstoichiometric molar 
ratio of hydroxide ions to iron ions of 1.4:1. Nowadays a sonochemical treatment is 
frequently used during the synthesis of IONPs or their hydrothermal ageing [3,69,70]. 
The coprecipitation under the ultrasonic irradiation results in spherical magnetite 
nanoparticles with higher crystallinity. The coprecipitation synthesis of naked magnetite 
and also that surface modified by organic compounds (oleic and mercaptopropionic 
acids and cetyltrimethylammonium bromide) was performed at 80oC under microwave 
heating for 8-15 minutes [71]. The obtained magnetite particles are of ~10 nm and 
rather homogeneous in size, but definitely aggregated in the sample of naked 
magnetite. 
        The naked IONPs are hydrophilic; their surface is fully covered by reactive ≡Fe-OH 
sites, which are hydrated and prone to react with several species from aqueous medium 
[41]. The IONPs gain charges in the protonation/deprotonation processes reacting with 
H+/OH- ions freely available in acidic and alkaline water, respectively. Therefore, 
positively charged IONPs exist below a characteristic pH (called point of zero charge 
(PZC)), which is around pH 8 for synthetic magnetite, while above it, IONPs carry 
negative charges due to deprotonation reaction [63, 72]. Coprecipitation was performed 
in diethyleneglycol at higher temperature then the formed IONP surface (PZC~7.2) was 
modified by silanization, and the change of pH-dependent charging was characterized 
by electrokinetic or zeta potential measurements providing direct evidence of sign and 
relative amount of charges [73].  
The in situ coating of coprecipitation product is widespread. The most often used 
coating agents are fatty acids, especially the oleic acid. The product of coprecipitation 
optimally at 80-82oC is magnetite, mostly single core with diameter 5-8 nm and having 
hydrophobic (chemisorbed oleate monolayer) or hydrophilic (due to a physisorbed 
secondary oleic acid layer) coating, the particles being dispersible in nonpolar solvents 
or water, respectively [26,64,74]. Beside efficient stabilization of MNPs in organic non-
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polar carriers, the oleic acid hydrophobic coating of IONPs organized in magnetic 
nanoparticle ensembles is particularly important in improving relaxivity in MR imaging, 
according to a recent evaluation [75]. The microwave assisted coprecipitation synthesis 
in the presence of in situ surface modifiers like oleic acid results in much lower degree 
of IONPs’ aggregation than that observed in their absence [71]. Recently, the so called 
one pot or single step synthesis procedure is preferred, which did not result in uniform 
product, but the quality of cores sometimes is promising. For example, a stoichiometric 
Fe(II) and Fe(III) salt mixture was hydrolysed in the mixture of diethylene glycol (DEG) 
and N-methyldiethanolamine (NMDA) at high temperature over the longer period to 
allow clustering and coalescence of the preformed seeds [76]. A single step procedure 
resulted in a big mixture of seemingly individual and definitely adhered (coalesced 
flower-like nanocrystals) maghemite nanoparticles, which had to be fractionated in 
acidic medium by increasing the ionic strength of the suspension, utilizing the basic 
principles of electrostatic colloidal stability. The mixture of particles formed in the single 
step synthesis and two examples selected from its fractions are shown in Fig. 2 to 
perceive the marked difference between the single and multicore IONPs.  
A similar, coprecipitation preparation strategy can be found in the latest literature [77]. 
However, the authors use microwave radiation to enhance the citrate mediated 
dissolution–recrystallisation process and state that their process yield a stable multi-
core dispersion with good reproducibility and that the synthesis procedure is potentially 
scalable. Exceptional magnetic heating parameters and good potential for future use 
are reported; nevertheless, neither the purification, i.e., removal excess citrate and 
dissolved iron nor the possible consequences (e.g., oxidative stress in vivo) were 
mentioned. The multicore nanoparticles, which can be considered as clusters of single 
cores of about 8–10 nm, are found to be very interesting for hyperthermia purposes 
[46].  
Preparation of naked (often called Massart-type [41]) magnetite NPs in the 
coprecipitation process results most probably in the mixture of single and multicore 
particles exclusively in all cases; however, the common purification of products involving 
magnetic separation (magnetic decantation) allows to remove more or less all 
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multicores leaving the electrostatically stabilized single cores in the acidified (e.g., [78]), 
or alkaline (e.g., [26]) aqueous medium.  
     The fact that ferrofluids may contain single or multicore particles probably influences 
not only their hyperthermia efficiency but also other properties. The core composition 
dependent flow properties of commercial biomedical ferrofluids have been started to 
investigate only very recently [25] and it turned out even from this preliminary study that 
ferrofluids of multicore particles have significant magnetoviscous effect leading to an 
external field dependent increase in viscosity, which is highly undesirable in vivo. Also 
quite recently, a study on the potential of magnetofection in delivering pDNA to cells and 
the effect of magnetic cell labeling on transfection efficacy has been published [54]. 
Multicore IONPs synthesized by common coprecipitation process followed by immediate 
spontaneous adsorption of organic shell components for magnetic cell labeling were 
proved to be effective for magnetophoretic delivery.  
      IONPs can form in biomineralization process. The natural product of magnetotactic 
bacteria, the magnetosomes are uniform particles of 20–45 nm core diameter, single 
domain crystals and the smaller ones are superparamagnetic [79]. Their structure is 
probably single core. Coprecipitation of ferrous and ferric ion at pH=9 without additives, 
in conditions of ultraslow crystal growth kinetics (5 to 480 minutes) similar to magnetite 
growth in magnetotactic bacteria, can deliver relatively large size magnetite 
nanoparticles (with “frozen” dipole moment) or even multi-domain particles, with non-
zero hysteresis losses [80].  
     Thermal decomposition of organo-metallic compounds (e.g., iron carbonyl, acetate, 
acetylacetonate, carboxylate) in organic solvents in the presence of a mixture of 
surfactants results in monodisperse nanoparticles of iron and/or iron oxides, with 
diameters ranging from 3 to 50 nm [81]. The products are also probably single core NPs 
coated with organic stabilizing shell. Appropriate organic compounds such as oleic acid, 
oleylamine are applied as in situ coating agents in each case of thermal decomposition 
of organic precursors as seen in the most cited paper of this method [82], in which the 
decomposition of Fe(acac)3 in an ether solution at higher temperature (typically first up 
to 200 oC and then up to 260–300 oC), in the presence of a polyol acting as reducing 
agent was studied. The reaction steps are monomer formation (decomposition of 
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organic precursor) followed by appearance of nuclei then their growth. Size of IONPs 
was controlled well through a seeded growth mechanism and monodisperse, 
hydrophobic NPs with size from 3-4 up to 20 nm have been obtained. The mixed 
magnetite and maghemite crystals with average sizes in the range 4−28 nm have been 
prepared by thermal decomposition of iron stearate in the presence of different 
surfactants [40]. The synthesis parameters (the quality of solvents and surfactants, the 
surfactant (ligand)/precursor ratio, the reaction time, the temperature) were varied, and 
no doubt that excellent monodisperse, single core (this term was not used in the paper) 
crystals were produced in different classes of size (e.g., 7-8, 10-11 nm). The formation 
of monodisperse NPs was explained qualitatively by LaMer nucleation model for 
designed synthesis of colloids. Each synthesized NP is superparamagnetic at room 
temperature and their saturation magnetization increases from 51 to 82 emu/g 
measured at 5K with increasing average TEM size of nanocrystals between 5.4 and 21 
nm. Oleic acid is among the most used and efficient surfactants in thermal 
decomposition, which may undergo loss of unsaturation when subjected to high 
temperatures specific to this synthesis route [83]. Prior to their use in biomedicine, 
phase transfer into aqueous media of the resulted hydrophobic IONPs is required, 
involving ligand exchange, addition of new functional groups or new coating layers of 
polymers or inorganic materials [3,10,19]. Various shape core-shell type nanoparticles 
were synthesized by thermal decomposition by varying the ligand nature (oleic acid 
and/or sodium oleate), the composition of the overall magnetic core itself involving the 
formation of an antiferromagnetic inner core Fe1-xO surrounded by a ferrimagnetic Fe3-
xO4 shell (Fig.3 a,b), a hydrophilic dendron coating ensuring good water dispersibility of 
the composite particles [84]. Due to the antiferromagnetic-ferrimagnetic composite 
nature of the magnetic core, the particles display highly improved in vitro as well as in 
vivo MRI properties. The significant magnetic spinel phase of the core gives high values 
for the magnetic moment density depending on the composite core size (Table 1).  
The major disadvantages of these thermal decomposition synthesis methods are that 
toxic organic solvents are used, the product NPs are coated chemically bound organic 
molecules and so the IONPs should be transferred into the aqueous phase. The latter  
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can be performed by means of surfactants (e.g. fatty acid salts like Na-oleate), which 
form an oppositely oriented second layer due to hydrophobic interaction with the alkyl 
chains of first layer chemisorbed on the surface of iron oxide NPs [74]. Long-term 
colloidal stability of aqueous nanoparticle dispersions in non-uniform magnetic field and 
in physiological conditions has not been proved yet [26]. If oleic acid is the surfactant in 
the synthesis, another possibility is the oxidization of double bond of chemisorbed 
oleate using strong oxidant like potassium permanganate under acidic or alkaline 
conditions, which leads to the formation of azelaic acid (an organic diacid) on the 
surface of IONPs and good water dispersibility of carboxylated product [85]. The other 
way is replacing the hydrophobic surfactants by hydrophilic molecules with anchoring 
chemical groups (e.g. carboxylic acid, phosphonic acid, dopamine) that have higher 
affinity to surface sites of IONPs in a ligand-exchange process widely used recently 
[86]. 
 
4. Designed synthesis of multicore iron oxide nanoparticles  
 
Iron oxide nanoparticle assemblies are receiving continuously increasing interest for 
diagnosis and treatment due to the newly acquired performances, especially in what 
concerns their magnetic response in targeting, local heating and MRI detection. The 
high magnetic moment of the functionalized multi-core carriers is among the most 
important requirements for successful applications in biomedicine, in particular for 
magnetic targeting [13,45]. The localization and amount of magnetic nanoparticles in 
the magnetic-nonmagnetic material structure, such as assembling onto the surface of a 
non-magnetic core [87], homogeneous distribution in a non-magnetic matrix, 
entrapment into a vesicle bilayer [19] or close packing into a magnetic core, which are 
essential for the overall magnetic response, favor the magnetic core-organic shell type 
nanostructures [88]. Magnetic nanoparticle clusters in a polymer shell, summing up the 
magnetic moments of individual nanoparticles, were obtained by in situ coprecipitation 
of magnetic nanoparticles in microgels as microreactors [79,80] and also by strongly 
polar solvent induced destabilization of a ferrofluid [53]. The controlled clusterization of 
magnetic nanoparticles using the well-established miniemulsion technique [91], followed 
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by encapsulation of the densely packed magnetic clusters in a polymer shell, is a 
successful joining of ferrofluid technology and oil-in-water miniemulsion procedure [92–
95]. Densely packed magnetic multi-core in thermoresponsive polymer shell obtained by 
ferrofluid miniemulsion procedure provided high magnetization spherical particles 
[57,96], promising for both efficient magnetic drug delivery and temperature controlled 
release. The surface density of oleic acid coating of individual MNPs controls the 
morphology of MNP clusters resulting in the oil-in-water miniemulsion process [50]. 
Incomplete OA coverage reduces the hydrophobicity of MNPs which tend to accumulate 
at the oil-water interface and gives rise to highly non-spherical shaped magnetic 
nanocomposites.  Multiple iron oxide cores (maghemite nanoparticles) assembled as 
magnetically cooperative multi-core particles were obtained by applying a single-step 
high temperature hydrolysis procedure [76] and also by chemical coprecipitation in a 
microwave reactor [77]. Loading of liposomes with iron oxide nanoparticles [97], mostly 
clusters preformed from aqueous [51] and organic [98] ferrofluids, gives rise to 
magnetoliposomes with high magnetophoretic mobility and MRI contrast, proved to be 
very effective in drug and gene delivery into cancer cells in vitro and in vivo. Magnetic 
nanocapsules containing iron oxide nanoparticles and anticancer drugs have been 
designed to provide highly magnetic carriers under moderate gradient magnetic fields 
for tumor penetration, which are responsive to remote RF field for ON–OFF switchable 
drug release [52]. The encapsulation of hydrophobically coated IONPs from ferrofluids 
together with camptothecin anticancer drug into PPO block of Pluronic vesicles, 
provided a scalable continuous manufacturing procedure to obtain multi-core 
theranostic drug delivery vehicles [99], which is a promising step in consolidating recent 
achievements in targeted drug delivery to cancer cells.  
The great variety of magnetic multi-core particles developed during the last few years, 
some of them reproduced in Fig.4, illustrate the progress in design and production of 
these versatile magnetic vectors with adjustable physicochemical properties (e.g., size, 
magnetic moment, surface charge, morphology, shell thickness), taking into account the 
requirements of achievable magnetic field strength and gradient, as well as of colloidal 
stability in biorelevant media. 
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The synthesis procedures, characteristic sizes and magnetic properties of several types 
of single-core and multi-core nanoparticles designed for biomedical applications are 
summarized in Table 1. 
 
5. Protection, stabilization and functionalization of magnetic nanoparticles by 
designed coating                      
The different synthesis ways mostly result in IONPs with coating shell, naked IONPs are 
not often prepared, probably because of their pH-dependent surface properties and 
strong aggregation in neutral aqueous environment as discussed above [63,73]. Good 
colloidal stability of IONPs, prevention of particle aggregation in biological milieu at 
certain pHs like pH~7.4 in blood and high salt and protein concentration in general are 
absolute requirements for biomedical applications [19, 72]. Therefore IONPs have to be 
coated either during or after their synthesis. The literature distinguishes in situ coating, 
post-synthesis adsorption or post-synthesis grafting [13]. In the latter polymer functional 
groups are anchored to the IONP’s surface, forming brush-like chains. As 
demonstrated, for example, in the work of Rinaldi and co-authors [110,111], covalent 
anchoring in many instances can enhance colloidal stability as compared with the 
adsorption of coating molecules. If a chemical surface modification is used, all the 
applied chemicals and by-products should be removed in order to reduce the chemical 
hazard of the formulation [112].  
Coatings largely influence not only the colloidal stability, but also the functionality and 
biological fate of IONPs. One can distinguish several diverse functions of coating, 
namely i) colloidal stabilization under physiological conditions (protecting against 
aggregation at biological pHs and salty medium), ii) inhibiting corrosion and oxidation of 
magnetic core (passivation reducing the iron leakage), iii) hindering non-specific protein 
adsorption in biological milieu, iv) providing reactive groups for grafting drugs and 
targeting molecules, and v) control nano-bio interfacial interactions 
(bio/hemocompatibility, reticuloendothelial system (RES) uptake, blood circulation time, 
IONP’s internalization efficiency, toxicity, targeting efficiency, in vivo fate, etc. as 
discussed in detail [10,13,19,112]).  
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      The colloidal stability, the interaction between particles is controlled by their collision 
frequency (thermal motion) and its efficiency, depending on the attractive and repulsive 
contributions of resulting interaction in aqueous medium. The classical theory of 
colloidal stability, the DLVO (Derjaguin, Landau and Verwey, Overbeek) theory 
describes the van der Waals and electrostatic forces. Besides these one should 
consider the hydration effects, the hydrophobic interactions  and the steric stabilization  
[113]. In case of magnetic particles, the attraction between magnetic dipoles, the 
magnetic dipolar interaction also should be considered [114] to get theoretical stability 
predictions comparable to experimental results [111].  
      The combined steric and electrostatic, called as electrosteric stabilization seems to 
be enough efficient, for example by polyelectrolyte (polyacrylic or polylactic acid, 
polyethylenimine, etc.) coating on IONPs; however, superb salt tolerance can be 
reached by coating with hydrophilic polymers like dextran, which is the most widely 
used polysaccharide in water-based magnetic fluids [7,12,19]. Frequently used coating 
agents are silica materials [115], small and big, natural and synthetic organic molecules 
(e.g., carboxylates, phosphates, phosphonate, sulfates, amines, alcohols, thiols, etc. 
[7,13, 72]). Mostly chemical bonds form between the functional groups of organic 
agents and reactive (both charged and uncharged) sites on the surface of IONPs. For 
example, in the well-known citrated magnetic fluids, the ≡Fe-OH sites are complexed by 
citrate through its OH and COOH groups [18] or by dopamine with both phenolic OH 
groups in the other favored core-shell product [7,19]). The effect of surface coverage 
changing with the amount of coating agent is poorly studied. Trace amounts of the 
polyacids can destabilize IONP dispersions at pH below PZC, while their high loading 
masks the original surface properties of IONPs and improves both colloidal stability and 
salt tolerance of dispersions [13]. In the presence of greater amounts of polyacids 
(above the adsorption saturation), the surface coverage of IONPs becomes completed 
causing a sign reversal of oxide particle charge and overcharging of nanoparticles 
enhancing their colloidal stability at pHs above ~5 [116]. The multi-site bonding is 
characteristic of macromolecular adsorption, which makes the coating layer resistant 
against dilution and easy the removal of excess from equilibrium medium [113].   
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In the editorial of  a very recent  ACSNano issue [118], the toxicity aspect of engineered 
nanomaterials (ENMs) is discussed and it has been stated, beside many important 
facts, that we must understand the ENMs’ properties (such as intrinsic material and 
extrinsic properties modified through interactions with the suspending medium, and 
dynamically emerge at the nano bio interface) responsible for the toxicological 
response; characterization should be performed in the relevant medium, and not simply 
in water, especially in case of ENMs aggregation (agglomeration) and re-engineered 
their physicochemical characteristics for risk prevention and safety use. Therefore 
colloidal stability of IONPs has to be satisfactory under physiological conditions, at 
biological pHs, in salty medium, in the presence of proteins and in cell culture media as 
well. Testing aggregation (DLS sizing, filtration test, visual observation of sedimentation) 
under arbitrary conditions is quite usual [19]. Coagulation kinetics experiment is a 
correct method to test the salt tolerance of IONPs, and so their resistance against 
aggregation in physiological environment can be predicted [73]. It was suggested a 
straightforward route of physicochemical (iron dissolution) and colloidal (pH-dependent 
charging and particle size, salt tolerance from coagulation kinetics) measurements to 
assess eligibility of IONPs for biomedical tests [18]. The biomedical use of citrated 
IONPs is favored in literature (e.g., the famous VSOP-C184 product in [3, 7, 28] or the 
very recent multi-core samples in [77]), however they coagulate much below the 
physiological salt concentration and even more the quantity of iron leaching from them 
is very high due to the reductive and complex forming ability of citric acid; the dissolved 
iron ions may cause oxidative stress besides the danger of particle aggregation in vivo. 
Amstad et al. [117] reported a similar iron dissolution effect of catechol derivatives 
anchored to Fe3O4 surfaces, especially mimosine anchoring , which has the highest 
affinity to Fe(III) ions leads to gradual dissolution of Fe3O4 nanoparticles through 
complexation. The other crucial point is the non-specific protein adsorption, the 
formation of protein corona in biological fluids [119]. To date the most widely accepted 
approach is to coat IONPs with hydrophilic polymers, among the several coating agents 
the most favored are polyethylene oxides or glycols (PEG) and carbohydrates such as 
dextran [10,19] or sugar derivatives [120] which are bound to NP surface chemically or 
by multiple hydrogen bonds and develop super hydrophilic cloud around IONPs, and so 
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can inhibit the surface accumulation of proteins. However, immediate protein corona 
formation on MNPs coated with dextran and its derivatives (carboxymethyl-dextran and 
diethylaminoethyl-dextran) was observed  recently [121]. Coating IONPs with PEG, 
grafted with poly(ethylene glycol)-silane [111] or in an one pot synthesis (thermal 
decomposition of Fe(acac)3 in the mixture of poly(ethylene glycol) and poly(ethylene 
imine) [122], i.e., their PEGylation can improve the pharmacokinetic profile of drug 
delivery systems, enhance the drug accumulation in tumor and may improve the blood-
brain barrier transport of IONPs [13].  
An artificial protein coating from bovine serum albumin (BSA) was designed to increase 
the colloidal stability of a lauric acid-coated IONPs [123]. It was revealed that BSA 
coating greatly reduced the toxicity of nanoparticles and that the mitoxantrone drug-
loaded system exhibited excellent therapeutic potential in vitro. The surface of 
magnetite cores was directly coated with BSA and further cross-linked to improve 
colloidal stability [124]. Monoclonal antibodies against vascular endothelial growth factor 
(mAbVEGF) were covalently conjugated to BSA coating on IONPs, which are promising 
MRI contrast agents for glioma visualization in brain.  
In biological environment, nanoparticles get contact with biological entities, forming 
nano-bio interfaces with dynamically interacting components of nanoparticle surface, its 
aqueous interface and the interface of contact zone with biological substrates [112]. 
Among these only the particle surface can be tailored in order to improve in vivo 
biocompatibility of NPs. In this respect, the main independent particle variables are the 
size, zeta potential (in relation with the sign and magnitude of surface charge) and 
dispersibility in aqueous media (hydrophilic/hydrophobic feature). Positively charged 
particles are more likely to be toxic than the larger relatively hydrophobic particles, 
which are rapidly removed by the RES system. Particles that promote enhanced 
permeation and retention (EPR) effects in biological systems generally have mid-range 
sizes and relatively neutral surface or weakly negative charges [112].  
 
6 Conclusions  
Magnetic iron oxide nanoparticles are the basic components of remote controlled 
nanoparticle systems for nanomedicine. They seem to fulfil most of biocompatibility and 
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specific formulation requirements related to magnetic field guided drug delivery and 
hyperthermia systems, as well as contrast agents. There are envisaged optimized 
synthesis procedures to ensure large scale and reproducible production of IONP 
systems with optimal surface properties, shape, size, biocompatibility and high magnetic 
moment. Especially targeting in depth requires focusing on the increase of the magnetic 
moment of particles.  In this respect recent results refer explicitly to single core and 
multi-core magnetic particles in strong correlation with colloidal stability in physiological 
environments, pharmacokinetics and in vivo fate of the two kinds of IONP systems.  
The main challenge is dual involving the design of magnetic core and its surface 
engineering to provide appropriate core-shell IONPs for theranostic purpose. Optimizing 
the synthesis of core with high magnetic moments, and the surface and colloid 
chemistry of coating as well in order to prepare feasible particles for the selected 
purpose in a reproducible way, is the main requirement of present researches in order 
to proceed further in scale up the manufacturing of various IONP systems. All of their 
magnetic, physical chemical and colloidal parameters (magnetic response, saturation 
magnetization, size, shape and chemistry of IONP crystals, hydrodynamic size and 
charge state at the given composition of equilibrium aqueous phase, dissolved iron and 
organic matter content) and propensities (hydrophilicity, pH-dependent charging and 
salt tolerance), which might be needed in biomedical use have to be characterized by 
correct laboratory methods in details before expensive in vitro and in vivo testing. More 
attention was paid recently to the required chemical and colloidal stability of IONPs and 
their nanobiointerfacial interactions in biological media, such as iron leaching from 
magnetic core due to its improper passivation by e.g., citrate coating, which increases 
oxidative stress in vivo, and more the leaching impurities (organic residuals, toxic ions 
like Cu2+) from chemical synthesis (e.g., click reaction); salt induced IONPs’ aggregation 
under physiological conditions, as well as non-specific protein adsorption and 
interactions with cell membranes in serum or any other biological media.  
The impressive progress in optimizing the composition, structure and functional 
coatings of iron oxide nanoparticle systems is a great promise for the design and 
reproducible manufacturing of single- and multi-core magnetoresponsive 
nanocomposites for specific applications in nanomedicine. 
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Table1. Single core (SCIO) and multi-core iron oxide (MCIO) magnetic particles 
systems 
Magnetic 
particles system 
Primary 
single-core 
IONP 
Preparation 
method 
Characteristics 
References Size  
(nm) 
Magnetic*  
naked SCIO  - coprecipitation  3-17a 26-89c [68] 
naked SCIO - coprecipitation 6.7-8.1a 52c ** [63] 
naked SCIO 
Fe3O4 - 
room temperature 
coprecipitation 
ultraslow rate 
15-47a 52-69c [80] 
SCIO Fe3O4/OA - 
coprecipitation  
microwave 
heating 
~10 a   - [71] 
SCIO Fe3O4/OA - coprecipitation 6.9 a 50c [64] 
SCIO / CA 
obtained by 
fractionation 
- 
 high temperature 
hydrolysis polyol 
approach 
10.3 a 57.5c [76] 
SCIO Fe3O4 /OA 
and OAm - 
Fe(acac)3 thermal 
decomposition 3 - 20 
a
 82 - 83c [82] 
SCIO  
maghemite / fatty 
acids and amines 
- 
thermal 
decomposition of 
iron stearate  
5.4 - 21 a 51 - 82c [40] 
SCIO 
FeO1-x@Fe3-xO4/ 
hydrophilic 
dendron 
- 
thermal 
decomposition of 
iron stearate 
14-20 a 26-41c [84] 
MCIO/CMD - 
modified alkaline 
precipitation 
method 
40 - 80 a - [22,23] 
MCIO /CTAB; 
MCIO /PEI; 
MCIO /PAA 
Fe3O4/OA-
Oam 
in hexane 
emulsion 30 - 88 a 60c [93] 
MCIO /SDS 
 
IONP/fatty 
acid 
(commercial  
product) 
emulsion 
 
45 – 79 a 
 
62c 
 
[95] 
MCIO /SDS/ 
hydrogel 
poly(NIPAM-AA) 
IONP/fatty 
acid 
(commercial 
product) 
emulsion/ 
precipitation 
polymerization 
 
145 -177a 
 
 
[95] 
 
MCIO / PEG-AA 
Fe3O4/OA 
in hexane 
(ferrofluid) 
emulsion-
templated 430-660 
a
 
7.5 – 24.8c 
15-43% g  
 
[92] 
MCIO/ 
PEI/PAAMA 
Fe3O4/OA 
in hexane emulsion ~1200 
a
 
~ 45 e 
 
[50] 
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(ferrofluid) 
MCIO/ SDS-
Tween 85; 
MCIO/CTAB-
Tween 85; 
MCIO/Pluronic 
PE 6800 
Fe3O4/OA 
in octane 
(ferrofluid) 
emulsion 50-300 a 57c  [100] 
MCIO / PBMA-g-
C12 
MnFe2O4 / 
OA emulsion 80 
a
 11 – 32c [101] 
MCIO in 
soybean, corn, 
cottonseed, olive 
oil or MCT/PEG-
DSPE 
Fe3O4/OA 
in toluene  
(ferrofluid) 
emulsion 30-95
b
 
 
- [102,103] 
MCIO/SDS/ PAA 
MCIO/SDS/ 
PNIPAM-PAA 
Fe3O4/OA 
toluene 
ferrofluid 
emulsion/ radical 
polymerization 100-200 
a
 43 – 46.8c [57] 
Silica coated 
magnetic 
nanocapsules 
(SiMNCs) 
Fe3O4/OA 
in octane 
emulsion/ 
silica coated of 
Fe3O4-
polystyrene 
nanospheres / 
polystyrene 
burned 
100 a ~ 45c [52] 
MCIO / PAA 
- 
hydrothermal 30-280 a 30.9 – 70c 
[58,104, 
105] 
MCIO / 
SiO2/PNIPAM 
 
MCIO / Carbon 
/PNIPAM  
- 
solvothermal / 
radical 
polymerization 
90–260 a 
 
160 a 
41.6c 
 
13.75c 
[106,107] 
MCIO / CA - 
microwave 
assisted 
coprecipitation 
13 - 17 a 65.2 – 72.9c [77] 
MCIO/Polymer 
embedded 
colloidal  
assemblies 
 
MnFe2O4 /LA; 
Fe3O4 / OA 
dispersed in 
toluene/ 
tetrahydro 
furane 
thermal 
decomposition/ 
colloid 
destabilization by 
acetonitrile 
 
70-134 a 
 
43e  
2.3x10-16 d 
 
[53] 
MCIO / CA 
obtained by 
fractionation 
- 
high temperature 
hydrolysis polyol 
approach 
19.7–
28.8 a 65.4-81.8
c
 [76] 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
MCIO 
- 
microwave 
irradiation 100 
a
 38.3c [108] 
MCIO/Polymer 
vesicle (Pluronic) 
IONP/OA 
dispersed in 
tetrahydro 
furane 
(ferrofluid) 
IONP embedded 
in polymer vesicle 
by 
microfluidic 
mixing 
~ 160 a 4.1-17.4% 
f
 
 
[99] 
 
MCIO/liposomes 
γ-Fe3O4/ 
citrate 
in water 
(ferrofluid) 
encapsulation of  
IONP into the 
liposomes 
200 a 24-33% 
g
 
 
[51] 
MCIO / 
liposomes-PEG 
Fe3O4  
in water 
(suspension) 
encapsulation of 
IONP into 
liposomes coated 
with PEG 
90 -110 
(AFM)  - [97] 
MCIO/liposomes-
PEG/PEG-Folic 
acid/Doxorubicin 
Fe3O4 
in water 
(commercial  
ferrofluid) 
encapsulation of 
IONP and 
doxorubicin into 
the liposomes 
coated with PEG 
and PEG+Folic 
acid 
156+-11 b 
361+-20 b 
 
- [109] 
 
Size: a TEM; b DLS 
Magnetic: c Ms-saturation magnetization (emu/g); d µ - magnetic moment (A.m2); e u-
magnetophoretic velocity (µm/s) 
Magnetic content-f IONP % (w/w) ; g IONP% (vol/vol) 
* Measurement at room temperature  
** data from the authors 
 
PCL-b-PEG : diblock copolymer of poly(ε-caprolactone)-b-poly(ethylene glycol) 
CTAB : cetyl trimethylammonium bromide 
PEI : poly(ethyleneimine) 
PAA : poly(acrylic acid) 
OA : oleic acid 
OAm : oleylamine 
SDS : sodium dodecyl sulfate 
NIPAM : N-isopropylacrylamine 
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AA : acrylic acid 
PEG : poly(ethylene glycol) 
PNIPAM : poly(N-isopropylacrylamine) 
PBMA-g-C12 : poly(isobutylene-alt-maleic anhydride) grafted with 1-dodecylamine 
CA – citric acid 
CMD – carboxymethyldextran 
MCT - medium chain triglycerides 
PEG-DSPE - distearoyl-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] 
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Fig.1. Cryo-TEM image of primary particles attaching to the surface of a magnetite 
nanoparticle (Reproduced from Ref.[67] with permission of the Nature Publishing 
Group). 
 
 
 
 
Fig. 2. TEM images of the polydisperse mixture of IONPs (as prepared left side) and its 
fractions containing multicore (MC1 middle) and single core (SC right side) 
nanoparticles (Reprinted with permission from [76]. Copyright (2012) American 
Chemical Society). 
 
Fig.3.  TEM images of antiferromagnetic-ferrimagnetic core-shell NPs: (a) nanospheres, 
(b) nanocubes. Insets show HRTEM images. Dashed lines indicate the Fe1-xO core and 
as prepared 
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solid lines indicate the Fe3−xO4 shell. (Reprinted with permission from [84]. Copyright 
(2014) American Chemical Society.) 
 
(1)   
(2)   
  
(3) 
 
Fig. 4 Magnetic multi-core particles obtained by different synthesis procedures:  
(1) encapsulation of MNPs into liposomes, polymersome: left - TEM (b) and cryo-
TEM (c) micrographs of Ultra Magnetic Liposomes (UMLs) prepared by reverse phase 
evaporation process (REV) process. MNPs are trapped inside unilamellar vesicles (c) 
and dipole−dipole interaction can occur as exemplified by magnification (b) (Reprinted 
with permission from [51]. Copyright (2012) American Chemical Society);  right - Cryo-
TEM image showing iron oxide nanoparticles incorporated in the polymersome 
membrane with 4.1% iron oxide (left), and 17.4% iron oxide (right). (Reproduced from 
Ref.[99] with permission of The Royal Society of Chemistry);  
(2) thermal decomposition: left - TEM images of polymer encapsulated colloidal 
ordered assemblies (polymer-COA) at higher (A) and lower (B) resolution. The dark 
pattern (A) results from the ordering of the closed packed assemblies within the 
nanobeads, while the brighter gray ring is caused by the polymer shell (lower electron 
density) of around 20 nm thickness. (Reprinted with permission from [53]. Copyright 
(2013) American Chemical Society); right – HRTEM of multi-core NP showing the 
continuity of the crystal lattice at the grain interfaces. The Fourier transform of this high-
resolution image (see inset) shows the monocrystalline fcc structure of the multi-core 
nanoparticles, oriented along the [001] zone axis. (Reprinted with permission from [76]. 
Copyright (2012) American Chemical Society); 
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(3) miniemulsion: left – TEM images of magnetic microgel with magnetite 
nanoparticles cluster as a core coated with two layers of cross linked polymer shells 
poly-N-isopropylacrylamide-polyacrylic acid(Reproduced from Ref.[57] with permission 
of The Royal Society of Chemistry); center - TEM image of magnetic clusters 
encapsulated in a copolymer hydrogel poly(N-isopropylacrylamide-acrylic acid). Scale 
bar: 100 nm.  (Reprinted with permission from [95]. Copyright (2011) American 
Chemical Society); right - TEM image of cross section of superparamagnetic 
microparticles produced with ferrofluid nanoparticle concentrations of 1 g/L using oil-in-
water emulsion-templated assembly. (Reprinted with permission from [50]. Copyright 
(2013) American Chemical Society) 
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Highlights: 
• Synthesis procedures of iron oxide nanoparticle systems are comparatively 
analysed 
• The properties of single core and multicore iron oxide nanoparticles are reviewed 
• Biocompatible functional coatings are thoroughly discussed
